$PMVP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PMV Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PMV Pharmaceuticals, Inc.. Get notifications about new insider transactions in PMV Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | PMVP | PMV Pharmaceutical ... | LEVINE ARNOLD J | Director | Sell | S | 34.09 | 111 | 3,783 | 420,342 | 420.5 K to 420.3 K (-0.03 %) |
Jun 22 2021 | PMVP | PMV Pharmaceutical ... | LEVINE ARNOLD J | Director | Sell | S | 33.22 | 3,389 | 112,579 | 420,453 | 423.8 K to 420.5 K (-0.80 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 585 | 19,118 | 129,980 | 130.6 K to 130 K (-0.45 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 11,485 | 375,330 | 2,533,517 | 2.5 M to 2.5 M (-0.45 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 3,317 | 108,400 | 731,673 | 735 K to 731.7 K (-0.45 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 3,063 | 100,099 | 675,551 | 678.6 K to 675.6 K (-0.45 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 2,183 | 71,340 | 481,386 | 483.6 K to 481.4 K (-0.45 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 1,121 | 37,710 | 129,565 | 130.7 K to 129.6 K (-0.86 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 22,070 | 742,435 | 2,545,002 | 2.6 M to 2.5 M (-0.86 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 6,372 | 214,354 | 734,990 | 741.4 K to 735 K (-0.86 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 5,883 | 197,904 | 678,614 | 684.5 K to 678.6 K (-0.86 %) |
Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 4,192 | 141,019 | 483,569 | 487.8 K to 483.6 K (-0.86 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 896 | 29,908 | 130,686 | 131.6 K to 130.7 K (-0.68 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 17,664 | 589,624 | 2,567,072 | 2.6 M to 2.6 M (-0.68 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 5,101 | 170,271 | 741,362 | 746.5 K to 741.4 K (-0.68 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 4,708 | 157,153 | 684,497 | 689.2 K to 684.5 K (-0.68 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 3,355 | 111,990 | 487,761 | 491.1 K to 487.8 K (-0.68 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 1,019 | 34,259 | 131,582 | 132.6 K to 131.6 K (-0.77 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 16,901 | 568,212 | 2,584,736 | 2.6 M to 2.6 M (-0.65 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 4,946 | 166,285 | 746,463 | 751.4 K to 746.5 K (-0.66 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 4,564 | 153,442 | 689,205 | 693.8 K to 689.2 K (-0.66 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 3,291 | 110,643 | 491,116 | 494.4 K to 491.1 K (-0.67 %) |
Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Stelzer Laurie | Director | Option Exercise | A | 32.29 | 16,333 | 527,393 | 16,333 | |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Jalota Deepika | SVP, Regulatory Aff ... | Option Exercise | A | 28.33 | 22,674 | 642,354 | 22,674 | |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | M | 3.90 | 4,000 | 15,600 | 365,850 | |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | A | 28.33 | 36,279 | 1,027,784 | 36,279 | |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 34.00 | 1,367 | 46,484 | 0 | 1.4 K to 0 (-100.00 %) |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 33.39 | 2,633 | 87,903 | 1,367 | 4 K to 1.4 K (-65.82 %) |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Buy | M | 3.90 | 4,000 | 15,600 | 4,000 | 0 to 4 K |
Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | A | 28.33 | 134,584 | 3,812,765 | 134,584 | |
May 27 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 35.66 | 7,487 | 266,986 | 2,043,629 | 2.1 M to 2 M (-0.37 %) |
May 27 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 35.91 | 8,518 | 305,881 | 2,051,116 | 2.1 M to 2.1 M (-0.41 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | M | 0.53 | 6,207 | 3,290 | 485,074 | |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | M | 0.53 | 6,207 | 3,290 | 485,074 | |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | M | 0.53 | 7,793 | 4,130 | 492,867 | |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | M | 0.53 | 7,793 | 4,130 | 492,867 | |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Sell | S | 35.71 | 6,207 | 221,641 | 2,470 | 8.7 K to 2.5 K (-71.53 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Sell | S | 35.71 | 6,207 | 221,641 | 2,470 | 8.7 K to 2.5 K (-71.53 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Buy | M | 0.53 | 6,207 | 3,290 | 8,677 | 2.5 K to 8.7 K (+251.30 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Buy | M | 0.53 | 6,207 | 3,290 | 8,677 | 2.5 K to 8.7 K (+251.30 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Sell | S | 35.60 | 7,793 | 277,455 | 2,470 | 10.3 K to 2.5 K (-75.93 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Sell | S | 35.60 | 7,793 | 277,455 | 2,470 | 10.3 K to 2.5 K (-75.93 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Buy | M | 0.53 | 7,793 | 4,130 | 10,263 | 2.5 K to 10.3 K (+315.51 %) |
May 24 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Buy | M | 0.53 | 7,793 | 4,130 | 10,263 | 2.5 K to 10.3 K (+315.51 %) |
May 12 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 35.67 | 1,787 | 63,742 | 2,104,414 | 2.1 M to 2.1 M (-0.08 %) |
May 10 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | M | 3.90 | 4,000 | 15,600 | 369,850 | |
May 10 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 35.49 | 158 | 5,607 | 0 | 158 to 0 (-100.00 %) |
May 10 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 34.80 | 3,842 | 133,702 | 158 | 4 K to 158 (-96.05 %) |
May 10 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Buy | M | 3.90 | 4,000 | 15,600 | 4,000 | 0 to 4 K |
May 07 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 35.64 | 600 | 21,384 | 2,106,201 | 2.1 M to 2.1 M (-0.03 %) |
May 04 2021 | PMVP | PMV Pharmaceutical ... | Kung Winston | COO, CFO | Option Exercise | M | 3.22 | 4,500 | 14,490 | 232,534 | |
May 04 2021 | PMVP | PMV Pharmaceutical ... | Kung Winston | COO, CFO | Sell | S | 33.75 | 4,500 | 151,875 | 1,600 | 6.1 K to 1.6 K (-73.77 %) |
May 04 2021 | PMVP | PMV Pharmaceutical ... | Kung Winston | COO, CFO | Buy | M | 3.22 | 4,500 | 14,490 | 6,100 | 1.6 K to 6.1 K (+281.25 %) |
Apr 13 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.11 | 100 | 3,311 | 2,106,801 | 2.1 M to 2.1 M (0.00 %) |
Apr 13 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.00 | 900 | 28,800 | 2,106,901 | 2.1 M to 2.1 M (-0.04 %) |
Apr 13 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.17 | 2,903 | 90,487 | 2,107,801 | 2.1 M to 2.1 M (-0.14 %) |
Apr 13 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.89 | 19,858 | 692,846 | 2,110,704 | 2.1 M to 2.1 M (-0.93 %) |
Apr 13 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.75 | 5,905 | 199,294 | 2,130,562 | 2.1 M to 2.1 M (-0.28 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.23 | 20,701 | 708,595 | 2,136,467 | 2.2 M to 2.1 M (-0.96 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.82 | 12,621 | 426,842 | 2,157,168 | 2.2 M to 2.2 M (-0.58 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.50 | 100 | 3,450 | 2,169,789 | 2.2 M to 2.2 M (0.00 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.88 | 24,357 | 825,215 | 2,169,889 | 2.2 M to 2.2 M (-1.11 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.67 | 67,086 | 2,325,872 | 2,194,246 | 2.3 M to 2.2 M (-2.97 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.85 | 11,571 | 391,678 | 2,261,332 | 2.3 M to 2.3 M (-0.51 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | M | 3.90 | 4,000 | 15,600 | 373,850 | |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 34.42 | 28 | 964 | 0 | 28 to 0 (-100.00 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 33.86 | 3,972 | 134,481 | 28 | 4 K to 28 (-99.30 %) |
Apr 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Buy | M | 3.90 | 4,000 | 15,600 | 4,000 | 0 to 4 K |
Apr 07 2021 | PMVP | PMV Pharmaceutical ... | BAUM CHARLES M | Director | Option Exercise | A | 34.11 | 32,677 | 1,114,612 | 32,677 | |
Apr 05 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.03 | 29,203 | 993,778 | 2,272,903 | 2.3 M to 2.3 M (-1.27 %) |
Apr 05 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.46 | 18,990 | 635,405 | 2,302,106 | 2.3 M to 2.3 M (-0.82 %) |
Apr 05 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.94 | 12,435 | 409,609 | 2,321,096 | 2.3 M to 2.3 M (-0.53 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.93 | 13,645 | 449,330 | 2,333,531 | 2.3 M to 2.3 M (-0.58 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.33 | 18,381 | 594,258 | 2,347,176 | 2.4 M to 2.3 M (-0.78 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.19 | 1,600 | 49,904 | 2,365,557 | 2.4 M to 2.4 M (-0.07 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.19 | 3,276 | 102,178 | 2,367,157 | 2.4 M to 2.4 M (-0.14 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 30.82 | 19,207 | 591,960 | 2,370,433 | 2.4 M to 2.4 M (-0.80 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.16 | 764 | 25,334 | 2,389,640 | 2.4 M to 2.4 M (-0.03 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.60 | 1,410 | 44,556 | 2,390,404 | 2.4 M to 2.4 M (-0.06 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.93 | 13,645 | 449,330 | 2,333,531 | 2.3 M to 2.3 M (-0.58 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.33 | 18,381 | 594,258 | 2,347,176 | 2.4 M to 2.3 M (-0.78 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.19 | 1,600 | 49,904 | 2,365,557 | 2.4 M to 2.4 M (-0.07 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.19 | 3,276 | 102,178 | 2,367,157 | 2.4 M to 2.4 M (-0.14 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 30.82 | 19,207 | 591,960 | 2,370,433 | 2.4 M to 2.4 M (-0.80 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.16 | 764 | 25,334 | 2,389,640 | 2.4 M to 2.4 M (-0.03 %) |
Mar 31 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 31.60 | 1,410 | 44,556 | 2,390,404 | 2.4 M to 2.4 M (-0.06 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 33.44 | 35,268 | 1,179,362 | 2,391,814 | 2.4 M to 2.4 M (-1.45 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.82 | 1,200 | 41,784 | 2,427,082 | 2.4 M to 2.4 M (-0.05 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 34.17 | 3,787 | 129,402 | 2,428,282 | 2.4 M to 2.4 M (-0.16 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 32.94 | 61,340 | 2,020,540 | 2,432,069 | 2.5 M to 2.4 M (-2.46 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 39.00 | 10,100 | 393,900 | 2,493,409 | 2.5 M to 2.5 M (-0.40 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 37.51 | 700 | 26,257 | 2,503,509 | 2.5 M to 2.5 M (-0.03 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 36.53 | 5,079 | 185,536 | 2,504,209 | 2.5 M to 2.5 M (-0.20 %) |
Mar 26 2021 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Sell | S | 35.12 | 19,002 | 667,350 | 2,509,288 | 2.5 M to 2.5 M (-0.75 %) |
Mar 25 2021 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | J | 0.00 | 2,269 | 0 | 2,269 | 0 to 2.3 K |
Mar 25 2021 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | J | 0.00 | 250 | 0 | 250 | 0 to 250 |
Mar 25 2021 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | J | 0.00 | 373 | 0 | 373 | 0 to 373 |
Mar 25 2021 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Mar 25 2021 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Mar 25 2021 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 5,469,911 | 6.5 M to 5.5 M (-15.46 %) |
Dec 31 2020 | PMVP | PMV Pharmaceutical ... | Kung Winston | COO, CFO | Option Exercise | M | 3.22 | 1,600 | 5,152 | 237,034 | |
Dec 31 2020 | PMVP | PMV Pharmaceutical ... | Kung Winston | COO, CFO | Buy | M | 3.22 | 1,600 | 5,152 | 1,600 | 0 to 1.6 K |
Nov 20 2020 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | M | 0.53 | 2,470 | 1,309 | 492,867 | |
Nov 20 2020 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Buy | M | 0.53 | 2,470 | 1,309 | 2,470 | 0 to 2.5 K |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 1,768,023 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 760,267 | 0 | 2,528,290 | 1.8 M to 2.5 M (+43.00 %) | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 1,768,023 | 0 | 1,768,023 | 0 to 1.8 M | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Buy | C | 0.00 | 760,267 | 0 | 760,267 | 0 to 760.3 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 132,601 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 751,409 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 2,601,637 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 693,769 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 132,601 | 0 | 132,601 | 0 to 132.6 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 751,409 | 0 | 751,409 | 0 to 751.4 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 2,601,637 | 0 | 2,601,637 | 0 to 2.6 M | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 1,768,023 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 693,769 | 0 | 693,769 | 0 to 693.8 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 760,267 | 0 | 2,528,290 | 1.8 M to 2.5 M (+43.00 %) | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 1,768,023 | 0 | 1,768,023 | 0 to 1.8 M | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Buy | C | 0.00 | 760,267 | 0 | 760,267 | 0 to 760.3 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 132,601 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 751,409 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 2,601,637 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 693,769 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 132,601 | 0 | 132,601 | 0 to 132.6 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 751,409 | 0 | 751,409 | 0 to 751.4 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 2,601,637 | 0 | 2,601,637 | 0 to 2.6 M | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 693,769 | 0 | 693,769 | 0 to 693.8 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 28,129 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 732,137 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 32,708 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 586,099 | 0 | 0 | ||
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 28,129 | 0 | 60,837 | 32.7 K to 60.8 K (+86.00 %) | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 32,708 | 0 | 32,708 | 0 to 32.7 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 732,137 | 0 | 2,268,236 | 1.5 M to 2.3 M (+47.66 %) | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 586,099 | 0 | 1,536,099 | 950 K to 1.5 M (+61.69 %) | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | P | 18.00 | 950,000 | 17,100,000 | 950,000 | 0 to 950 K | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 114,039 | 0 | 0 | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 380,133 | 0 | 0 | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 518,191 | 0 | 0 | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,076,891 | 0 | 0 | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,025,076 | 0 | 0 | |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 114,039 | 0 | 114,039 | 0 to 114 K |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 380,133 | 0 | 6,475,291 | 6.1 M to 6.5 M (+6.24 %) |
Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 518,191 | 0 | 6,095,158 | 5.6 M to 6.1 M (+9.29 %) |